BerandaLCTX • NYSEAMERICAN
add
Lineage Cell Therapeutics Inc
$0,58
Sebelum Jam Perdagangan Normal:(2,34%)-0,014
$0,57
Tutup: 13 Jan, 04.21.18 GMT-5 · USD · NYSEAMERICAN · Pernyataan Penyangkalan
Tutup sebelumnya
$0,53
Rentang hari
$0,51 - $0,58
Rentang tahun
$0,48 - $1,61
Kapitalisasi pasar
128,37Â jt USD
Volume Rata-Rata
3,17Â jt
Rasio P/E
-
Hasil dividen
-
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(USD) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 3,78Â jt | 203,29% |
Biaya operasional | 4,41Â jt | 9,13% |
Laba bersih | -3,03Â jt | 57,33% |
Margin laba bersih | -80,29 | 85,93% |
Penghasilan per saham | -0,02 | 50,37% |
EBITDA | -3,70Â jt | 43,35% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
(USD) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 32,71Â jt | -20,86% |
Total aset | 96,59Â jt | -9,00% |
Total liabilitas | 31,80Â jt | -19,48% |
Total ekuitas | 64,79 jt | — |
Saham yang beredar | 188,84 jt | — |
Harga terhadap nilai buku | 1,52 | — |
Tingkat pengembalian aset | -9,63% | — |
Tingkat pengembalian modal | -13,98% | — |
Arus Kas
Perubahan kas bersih
(USD) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | -3,03Â jt | 57,33% |
Kas dari operasi | -5,79Â jt | -14,89% |
Kas dari investasi | 3,89Â jt | 83,22% |
Kas dari pembiayaan | -3,00Â rb | -100,37% |
Perubahan kas bersih | -1,86Â jt | 23,86% |
Arus kas bebas | -2,27Â jt | 12,27% |
Tentang
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Didirikan
1990
Situs
Karyawan
72